DLG1 promotes the antiviral innate immune response by inhibiting p62-mediated autophagic degradation of IKKε

J Virol. 2023 Dec 21;97(12):e0150123. doi: 10.1128/jvi.01501-23. Epub 2023 Nov 20.

Abstract

The type-I interferon (IFN-I) signaling pathway is the first line of antiviral innate immunity. It must be precisely regulated against virus-induced damage. The tightly regulated mechanisms of action of host genes in the antiviral innate immune signaling pathway are still worth studying. Here, we report a novel role of DLG1 in positively regulating the IκB kinase epsilon (IKKε)-mediated IFN-I signaling response against negative-stranded RNA virus replication, whereas the RNA virus inhibits the expression of DLG1 for immune escape. Importantly, the E3 ligase March2 interacts with and promotes K27-linked polyubiquitination of IKKε, and p62 is a cargo receptor that recognizes ubiquitinated IKKε for eventual autophagic degradation. Together, the current findings elucidate the role of DLG1 in the antiviral IFN-I signaling pathway and viral infection repression.

Keywords: DLG1; IKKε; autophagy; innate immunity; interferon; ubiquitination.

MeSH terms

  • Animals
  • Autophagy*
  • Cell Line
  • Discs Large Homolog 1 Protein* / metabolism
  • Humans
  • I-kappa B Kinase* / metabolism
  • Immunity, Innate* / immunology
  • Negative-Sense RNA Viruses* / growth & development
  • Negative-Sense RNA Viruses* / immunology
  • Polyubiquitin / metabolism
  • Sequestosome-1 Protein* / antagonists & inhibitors
  • Signal Transduction
  • Virus Diseases* / immunology

Substances

  • Discs Large Homolog 1 Protein
  • DLG1 protein, human
  • I-kappa B Kinase
  • MARCHF2 protein, human
  • Polyubiquitin
  • Sequestosome-1 Protein
  • SQSTM1 protein, human